Gov. Hutchinson signs bill into law that ensures insurance coverage for colorectal screenings for men and women across Arkansas starting at the age of 45 and removes cost-sharing for a follow-up colonoscopy following a positive stool-based screening test.
Gov. Stitt signs a bill into law to help patients afford appropriate prescriptions.
TALLAHASSEE, FL – Today, SB 1080 – a bill disguised as a solution to the youth tobacco epidemic – was passed by the Senate Rules Committee with an 11-5 vote. The bill will be heard next on the full Senate floor.
SPRINGFIELD, IL – Today, the House of Representatives unanimously passed legislation to expand coverage of biomarker testing – an essential step in accessing precision medicine treatments.
PORTLAND, ME – Today, state legislators heard from cancer and cardiovascular patients, survivors, and public health advocates during Maine’s virtual Tobacco Action Day.
AUSTIN, TX – April 13, 2021 – Sponsored by Sen. Huffman and Sen. Zaffirini, SB 1028 will be heard by the Senate Business and Commerce Committee today at 8 a.m.
BATON ROUGE, LA – As lawmakers dive into the new legislative session, the American Cancer Society Cancer Action Network (ACS CAN) looks ahead to what public health initiatives our lawmakers can accomplish during the 2021 legislative session.
Karen E. Knudsen, MBA, Ph.D., will be the next chief executive officer of the American Cancer Society (ACS) and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN), starting June 1, 2021. She will take the reins from the retiring Gary Reedy, who has served as both organizations’ CEO since 2015.
HONOLULU—The Senate will have its final vote tomorrow, Tuesday, April 13, on House Bill 1296 that would dismantle Hawaii’s Tobacco Prevention and Control Trust Fund, which has significantly reduced smoking rates for more than two decades.
Today the Biden administration released preliminary details on its FY 2022 discretionary budget, including $6.5 billion to create a new department within the National Institutes of Health (NIH) dedicated to accelerating the pace of biomedical research for rare and difficult to treat diseases.